Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Jul 24, 2026
YINN's +18% Rebound: Analyzing the Direxion Daily FTSE China Bull 3X Shares Recovery

YINN's +18% Rebound: Analyzing the Direxion Daily FTSE China Bull 3X Shares Recovery

Key Takeaways

  • YINN surged approximately 18% over the past 30 days, recovering sharply from multi-month lows reached in late June 2026.
  • The ETF remains down roughly 18% over the last quarter, reflecting a volatile V-shaped trajectory: a prolonged selloff followed by a powerful policy-driven rebound.
  • Coordinated interventions by Chinese state-owned capital platforms, large-scale share buybacks, and insurer equity pledges served as the primary catalysts for the recent rally.
  • Foreign institutional sentiment turned markedly more constructive, with Citigroup upgrading Chinese equities to overweight and the IMF raising China's 2026 GDP growth forecast to 4.6%.
  • As a 3x daily leveraged product, YINN amplified both the preceding drawdown and the subsequent recovery, underscoring the elevated volatility inherent in leveraged ETF strategies.

Understanding YINN's Structure and Exposure

Direxion Daily FTSE China Bull 3X Shares (YINN) is a leveraged ETF that seeks to deliver 300% of the daily performance of the FTSE China 50 Index, before fees and expenses. The underlying index comprises the 50 largest and most liquid Chinese companies listed on the Hong Kong Stock Exchange, spanning financials, consumer discretionary, communication services, and technology. YINN achieves its leveraged exposure primarily through swap agreements and a substantial position in the FXI (iShares China Large-Cap ETF), which typically accounts for approximately 60% of net assets. The fund carries an expense ratio of 1.34% and had net assets of roughly $500 million as of mid-2026. Its non-diversified, swap-intensive structure means performance is highly sensitive to daily index moves multiplied by the 3x leverage factor, making it best suited for short-term tactical trading rather than buy-and-hold strategies. I also checked comparable leveraged products using Tickeron’s AI Screener to see how YINN stacks up in terms of volatility metrics.

YINN's Price Moves Over the Past Month and Quarter

Over the past 30 days, YINN climbed approximately 18%, rebounding from a closing low of $23.20 on June 24 to $27.41 by July 23. The rally was not linear; the ETF experienced elevated daily swings characteristic of leveraged products, with several single-day moves exceeding 5% in either direction. Over the broader quarterly window, YINN declined roughly 18%, having traded near $33.38 in late April before a multi-week selloff driven by global risk-off sentiment and external contagion dragged it to its late-June trough. The resulting V-shaped pattern highlights the ETF's acute sensitivity to shifts in Chinese equity sentiment, with 3x daily leverage compressing both the drawdown and the recovery into amplified moves.

Key Factors Behind the Recent Rally

The sharp rebound in YINN was fueled by a confluence of policy interventions and improving investor sentiment toward Chinese equities. In mid-July, China's Securities Regulatory Commission (CSRC) convened a series of investor and industry symposiums, signaling a commitment to market stability and countercyclical regulation. Two state-owned capital platforms, China Reform Holdings and China Chengtong Holdings, announced large-scale stock purchases totaling approximately 600 billion yuan, deploying both self-owned funds and the central bank's share buyback relending facility. Nearly 300 listed companies completed share repurchases exceeding 15 billion yuan in July alone, while major insurers including Ping An, China Life, and CPIC pledged to increase equity allocations toward technology, advanced manufacturing, and other strategic sectors.

External catalysts reinforced the recovery. The IMF upgraded China's 2026 growth forecast to 4.6%, citing robust high-tech manufacturing output and export resilience. Citigroup raised its rating on Chinese equities to overweight, while UBS and Standard Chartered maintained constructive stances, citing attractive valuations and accelerating AI-driven earnings growth. The technology-heavy STAR 50 Index surged over 10% in a single session on July 21, and Hong Kong-listed Chinese large caps tracked by the FTSE China 50 Index posted strong gains. Since YINN's portfolio is effectively a 3x levered bet on those same large-cap Chinese names, the rally translated into outsized gains for the ETF. I ran a quick comparison of sector exposures through Tickeron’s AI Screener to confirm the alignment with the underlying index moves.

Understanding the Quarterly Drawdown

The broader quarterly decline in YINN reflects the substantial drawdown that preceded the late-June policy pivot. From late April through mid-June, Chinese equities faced multiple headwinds. Global risk aversion spiked amid escalating US-Iran geopolitical tensions, rising US Treasury yields, and a recalibration of AI-related valuations across global markets. Contagion from sharp selloffs in US and South Korean technology shares rippled into Hong Kong-listed Chinese stocks. Within China, pre-existing concerns about deflationary pressures, property sector weakness, and high trading congestion in tech names contributed to a significant unwind. The FTSE China 50 Index fell over 5% during the second quarter, and with 3x daily leverage applied, YINN's quarterly decline was amplified to approximately 18% despite the late-period recovery. The quarter thus illustrates the dual-edged nature of leveraged ETF exposure: sustained downtrends compound losses rapidly, while sentiment reversals can generate similarly powerful snapbacks.

YINN ETF Outlook: What Investors Should Watch Next

The trajectory of YINN in the months ahead will depend heavily on whether the policy-driven stabilization in Chinese equities can transition into a more durable, fundamentals-supported recovery. Key factors to monitor include the follow-through on state-owned capital platform purchase commitments, the pace of additional stimulus measures targeting domestic consumption and the property sector, and the trajectory of corporate earnings as mid-year reporting season progresses. On the macroeconomic front, inflation data, PMI readings, and credit growth figures will provide signals on whether China's economic recovery is gaining traction. Externally, US Federal Reserve policy expectations, US-China trade relations, and global risk appetite will influence capital flows into Hong Kong-listed Chinese shares. Given YINN's 3x daily leverage structure, investors should also closely track daily index volatility, as decay effects and compounding can meaningfully impact returns over holding periods longer than a single trading session. The ETF remains a high-octane instrument suited primarily for those with a short-term tactical view on Chinese large-cap equities and a high tolerance for amplified volatility.

Using AI Tools in My Research Process

When evaluating volatile leveraged ETFs like YINN, I frequently rely on Tickeron’s AI Screener to scan thousands of securities for technical indicators, volatility measures, price patterns, and AI-generated signals. It allows me to quickly surface candidates that align with specific performance or risk profiles, streamlining what would otherwise be a time-consuming manual process. This approach has become a regular part of how I cross-check sector exposures and compare emerging-market opportunities before making tactical decisions.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: YINN

Contributor

My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.


YINN's RSI Indicator climbs out of oversold territory

The RSI Indicator for YINN moved out of oversold territory on October 05, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 30 similar instances when the indicator left oversold territory. In 29 of the 30 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +6.14% 3-day Advance, the price is estimated to grow further. Considering data from situations where YINN advanced for three days, in 224 of 255 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.

YINN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on YINN as a result. In 100 of 107 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

YINN moved below its 50-day moving average on September 08, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for YINN crossed bearishly below the 50-day moving average on September 11, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where YINN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for YINN entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Industry description

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the FTSE China 50 Index. The fund, under normal circumstances, invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments, such as swap agreements, securities of the index, and exchange-traded funds ("ETFs") that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index consists of the 50 largest and most liquid public Chinese companies currently trading on the Hong Kong Stock Exchange. The fund is non-diversified.
View a ticker or compare two or three
YINN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Trading

Category
Trading--Leveraged Equity
Address
Direxion Shares ETF Trust33 Whitehall Street,10th FloorNew York
Phone
866-476-7523
Web
http://www.direxioninvestments.com/
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
Patterson-UTI Energy, Inc. (PTEN) stands out as a leading provider of drilling and completion services to oil and natural gas exploration and production companies, primarily in the United States and select international markets. The company operates through three main segments: Drilling Services, which includes contract drilling rigs and directional drilling; Completion Services, encompassing hydraulic fracturing, wireline, and pumping; and Drilling Products, offering specialized drill bits globally, including in the Middle East.
As a provider of onshore drilling and completion services, Patterson-UTI Energy (PTEN) is gearing up for a key Q1 2026 earnings report against the backdrop of fluctuating oil prices and steady U.S. rig demand. The company's integrated approach across Drilling Services, Completion Services, and Drilling Products gives it a solid footing in North American shale plays. In my view, recent quarters like Q4 2025, where revenue exceeded estimates despite a net loss, highlight its resilience. This upcoming report will offer insights into activity levels, margin trends, and capital discipline amid supply growth and geopolitical tensions. With strong free cash flow and recent dividend increases, PTEN's focus on shareholders stands out, making this a critical gauge for the 2026 outlook in the cyclical oilfield services sector.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.
YINN's +18% Rebound: Analyzing the Direxion Daily FTSE China Bull 3X Shares Recovery